Strategies to Reduce HCV Incidence in At-Risk European Populations

Complimentary slides from CCO featuring an in-depth analysis of HCV burden and care disparities in specific populations and strategies to reduce disparities.

Expert insights on special considerations for individuals with HCV in ethnically diverse populations, from Ahmed M. Elsharkawy PhD, FRCP(UK), and Clinical Care Options (CCO)

Ahmed M. Elsharkawy, PhD, FRCP(UK) Released: December 1, 2021

Clinical Care Options (CCO) podcast with Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 1, 2021

Clinical Care Options (CCO) expert analysis by Dr. Stefan Zeuzem on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Stefan Zeuzem, MD Released: November 30, 2021